# Trade Mark Journal No.2026/013 27 March 2026

## WO0000001907101 (5)

Office of origin: United States of America

Date of International Registration:4 February 2026
Date of designation in the UK: 4 February 2026

International priority date claimed: 7 August 2025 (Jamaica) (95510)

Class 5
  Pharmaceutical preparations for the treatment of endocrine, metabolic, and hormonal related diseases and disorders.

Amylyx Pharmaceuticals, Inc.

Representative: Fish & Richardson P.C., PO Box 1022, Minneapolis MN 55440-1022, UNITED STATES OF AMERICA